Evidence map›Paper›PMID 29073044›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

SMELL-S and SMELL-R: Olfactory tests not influenced by odor-specific insensitivity or prior olfactory experience.

Julien W Hsieh, Andreas Keller, Michele Wong, Rong-San Jiang, Leslie B Vosshall

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Odor Discrimination as a Marker of Early Alzheimer's Disease.Journal of Alzheimer's disease : JAD · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. International consensus statement on allergy and rhinology: Olfaction.International forum of allergy & rhinology · 2022
    Review
  18. Article
  19. Article
  20. Altered Functional Connectivity Strength of Primary Visual Cortex in Subjects with Diabetic Retinopathy.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Julien W HsiehLaboratory of Neurogenetics and Behavior, The Rockefeller University, New York, NY 10065; hsiehjulien@gmail.com Leslie.Vosshall@rockefeller.edu.ORCID 0000-0001-7675-1239
Andreas KellerLaboratory of Neurogenetics and Behavior, The Rockefeller University, New York, NY 10065.ORCID 0000-0001-5491-2214
Michele WongLaboratory of Neurogenetics and Behavior, The Rockefeller University, New York, NY 10065.ORCID 0000-0002-5123-1330
Rong-San JiangDepartment of Otolaryngology, Taichung Veterans General Hospital, Xitun District, Taichung City, Taiwan 407.
Leslie B VosshallLaboratory of Neurogenetics and Behavior, The Rockefeller University, New York, NY 10065; hsiehjulien@gmail.com Leslie.Vosshall@rockefeller.edu.ORCID 0000-0002-6060-8099
Rockefeller University · USHoward Hughes Medical Institute · USTaichung Veterans General Hospital · TWUniversity Hospital of Geneva · CH

Funding

Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational SuccessUL1TR001866 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY, KRUEGER, JAMES G · 2016 to 2025
$40.6M
Transforming Translational Science and Education to Benefit Human HealthUL1TR000043 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY · 2012 to 2015
$26.8M
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR000043NCATS NIH HHS UL1 TR001866
6 · The paper itself

Abstract

Smell dysfunction is a common and underdiagnosed medical condition that can have serious consequences. It is also an early biomarker of neurodegenerative diseases, including Alzheimer's disease, where olfactory deficits precede detectable memory loss. Clinical tests that evaluate the sense of smell face two major challenges. First, human sensitivity to individual odorants varies significantly, so test results may be unreliable in people with low sensitivity to a test odorant but an otherwise normal sense of smell. Second, prior familiarity with odor stimuli can bias smell test performance. We have developed nonsemantic tests for olfactory sensitivity (SMELL-S) and olfactory resolution (SMELL-R) that use mixtures of odorants that have unfamiliar smells. The tests can be self-administered by healthy individuals with minimal training and show high test-retest reliability. Because SMELL-S uses odor mixtures rather than a single molecule, odor-specific insensitivity is averaged out, and the test accurately distinguished people with normal and dysfunctional smell. SMELL-R is a discrimination test in which the difference between two stimulus mixtures can be altered stepwise. This is an advance over current discrimination tests, which ask subjects to discriminate monomolecular odorants whose difference in odor cannot be quantified. SMELL-R showed significantly less bias in scores between North American and Taiwanese subjects than conventional semantically based smell tests that need to be adapted to different languages and cultures. Based on these proof-of-principle results in healthy individuals, we predict that SMELL-S and SMELL-R will be broadly effective in diagnosing smell dysfunction.

Indexed as

AdultAgedFemaleHumansMaleMiddle AgedNorth AmericaOdorantsOlfaction DisordersOlfactometryPhenylethyl AlcoholRecognition, PsychologyReproducibility of ResultsSemanticsSensory ThresholdsSmellPhenylethyl Alcoholhyposmiaodor-specific insensitivityolfactionolfactory dysfunctionsmell test

Identifiers

PMID29073044
PMCPMC5664538
OpenAlexW2949847084

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.